Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/13/15 → 1/13/18 |
Funding
- SynteractHCR, Inc. (Prot #CLT008-03 // Prot #CLT008-03)
- Cellerant Therapeutics, Inc. (Prot #CLT008-03 // Prot #CLT008-03)
Prot #CLT008-03: An Open-label Phase 2 Prospective, Randomized, Controlled Study of CLT-008 Myeloid Progenitor Cells As A Supportive Care Measure During Induction Chemotherapy For Acute Myeloid Leukemia
- Frankfurt, Olga (PD/PI)
Project: Research project